Cargando…

Risperidone Associated Paralytic Ileus in Schizophrenia

A 32-year-old man, diagnosed with catatonic schizophrenia, was treated with risperidone and lorazepam in the general hospital psychiatry setup. He developed signs of intestinal obstruction, which was diagnosed as paralytic ileus and was treated conservatively along with stopping the offending drug....

Descripción completa

Detalles Bibliográficos
Autores principales: Ramamourthy, Parthasarathy, Kumaran, Arunkumar, Kattimani, Shivanand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701367/
https://www.ncbi.nlm.nih.gov/pubmed/23833349
http://dx.doi.org/10.4103/0253-7176.112214
_version_ 1782275628585713664
author Ramamourthy, Parthasarathy
Kumaran, Arunkumar
Kattimani, Shivanand
author_facet Ramamourthy, Parthasarathy
Kumaran, Arunkumar
Kattimani, Shivanand
author_sort Ramamourthy, Parthasarathy
collection PubMed
description A 32-year-old man, diagnosed with catatonic schizophrenia, was treated with risperidone and lorazepam in the general hospital psychiatry setup. He developed signs of intestinal obstruction, which was diagnosed as paralytic ileus and was treated conservatively along with stopping the offending drug. Risperidone is said to be devoid of anticholinergic side effects, but prevalence of these varies from 7% to 13% in patients receiving treatment for schizophrenia. Constipation has been reported but fatal adverse effect like paralytic ileus with risperidone is rarely reported. Timely diagnosis can save the need for surgical interventions and fatal complications. This predisposition in schizophrenia could be due to neurodevelopmentally shared abnormality of brain and gut nervous system.
format Online
Article
Text
id pubmed-3701367
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37013672013-07-05 Risperidone Associated Paralytic Ileus in Schizophrenia Ramamourthy, Parthasarathy Kumaran, Arunkumar Kattimani, Shivanand Indian J Psychol Med Case Report A 32-year-old man, diagnosed with catatonic schizophrenia, was treated with risperidone and lorazepam in the general hospital psychiatry setup. He developed signs of intestinal obstruction, which was diagnosed as paralytic ileus and was treated conservatively along with stopping the offending drug. Risperidone is said to be devoid of anticholinergic side effects, but prevalence of these varies from 7% to 13% in patients receiving treatment for schizophrenia. Constipation has been reported but fatal adverse effect like paralytic ileus with risperidone is rarely reported. Timely diagnosis can save the need for surgical interventions and fatal complications. This predisposition in schizophrenia could be due to neurodevelopmentally shared abnormality of brain and gut nervous system. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3701367/ /pubmed/23833349 http://dx.doi.org/10.4103/0253-7176.112214 Text en Copyright: © Indian Journal of Psychological Medicine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ramamourthy, Parthasarathy
Kumaran, Arunkumar
Kattimani, Shivanand
Risperidone Associated Paralytic Ileus in Schizophrenia
title Risperidone Associated Paralytic Ileus in Schizophrenia
title_full Risperidone Associated Paralytic Ileus in Schizophrenia
title_fullStr Risperidone Associated Paralytic Ileus in Schizophrenia
title_full_unstemmed Risperidone Associated Paralytic Ileus in Schizophrenia
title_short Risperidone Associated Paralytic Ileus in Schizophrenia
title_sort risperidone associated paralytic ileus in schizophrenia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701367/
https://www.ncbi.nlm.nih.gov/pubmed/23833349
http://dx.doi.org/10.4103/0253-7176.112214
work_keys_str_mv AT ramamourthyparthasarathy risperidoneassociatedparalyticileusinschizophrenia
AT kumaranarunkumar risperidoneassociatedparalyticileusinschizophrenia
AT kattimanishivanand risperidoneassociatedparalyticileusinschizophrenia